Notably, a whole-genome CRISPR activation screen in 2023 revealed that sex hormones can upregulate the expression of membrane-bound o-acyltransferase domains 1 and 2 (MBOAT1/2) which contribute in preventing the ferroptosis in cancer cells lacking GPX4 and FSP1 [41]. This evidence concerns the gene GPX4 and cancer.